annual cash & cash equivalents:
$26.68M-$28.84M(-51.95%)Summary
- As of today (June 26, 2025), VKTX annual cash & cash equivalents is $26.68 million, with the most recent change of -$28.84 million (-51.95%) on December 31, 2024.
- During the last 3 years, VKTX annual cash & cash equivalents has risen by +$305.00 thousand (+1.16%).
- VKTX annual cash & cash equivalents is now -51.95% below its all-time high of $55.52 million, reached on December 31, 2023.
Performance
VKTX Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$37.94M+$11.26M(+42.23%)Summary
- As of today (June 26, 2025), VKTX quarterly cash & cash equivalents is $37.94 million, with the most recent change of +$11.26 million (+42.23%) on March 31, 2025.
- Over the past year, VKTX quarterly cash & cash equivalents has dropped by -$157.64 million (-80.60%).
- VKTX quarterly cash & cash equivalents is now -80.60% below its all-time high of $195.58 million, reached on March 31, 2024.
Performance
VKTX quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
VKTX Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -52.0% | -80.6% |
| 3 y3 years | +1.2% | +204.6% |
| 5 y5 years | +218.4% | +148.6% |
VKTX Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -52.0% | +1.2% | -80.6% | +204.6% |
| 5 y | 5-year | -52.0% | +218.4% | -80.6% | +880.4% |
| alltime | all time | -52.0% | >+9999.0% | -80.6% | >+9999.0% |
VKTX Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $37.94M(+42.2%) |
| Dec 2024 | $26.68M(-51.9%) | $26.68M(-47.0%) |
| Sep 2024 | - | $50.35M(+14.6%) |
| Jun 2024 | - | $43.91M(-77.5%) |
| Mar 2024 | - | $195.58M(+252.3%) |
| Dec 2023 | $55.52M(+51.6%) | $55.52M(+49.3%) |
| Sep 2023 | - | $37.19M(-46.5%) |
| Jun 2023 | - | $69.52M(+278.6%) |
| Mar 2023 | - | $18.36M(-49.9%) |
| Dec 2022 | $36.63M(+38.9%) | $36.63M(+24.6%) |
| Sep 2022 | - | $29.41M(+81.2%) |
| Jun 2022 | - | $16.23M(+30.3%) |
| Mar 2022 | - | $12.45M(-52.8%) |
| Dec 2021 | $26.37M(-9.4%) | $26.37M(+134.1%) |
| Sep 2021 | - | $11.26M(+27.6%) |
| Jun 2021 | - | $8.83M(-47.5%) |
| Mar 2021 | - | $16.80M(-42.3%) |
| Dec 2020 | $29.12M(+247.6%) | $29.12M(+652.4%) |
| Sep 2020 | - | $3.87M(-79.4%) |
| Jun 2020 | - | $18.79M(+23.1%) |
| Mar 2020 | - | $15.26M(+82.2%) |
| Dec 2019 | $8.38M | $8.38M(-72.9%) |
| Sep 2019 | - | $30.95M(+61.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $19.12M(+33.3%) |
| Mar 2019 | - | $14.34M(-42.1%) |
| Dec 2018 | $24.78M(+175.7%) | $24.78M(-85.4%) |
| Sep 2018 | - | $169.51M(+389.8%) |
| Jun 2018 | - | $34.61M(-4.8%) |
| Mar 2018 | - | $36.36M(+304.5%) |
| Dec 2017 | $8.99M(+192.2%) | $8.99M(+250.0%) |
| Sep 2017 | - | $2.57M(-24.3%) |
| Jun 2017 | - | $3.39M(-22.1%) |
| Mar 2017 | - | $4.36M(+41.7%) |
| Dec 2016 | $3.08M(+300.2%) | $3.08M(+0.7%) |
| Sep 2016 | - | $3.05M(-40.8%) |
| Jun 2016 | - | $5.16M(+30.3%) |
| Mar 2016 | - | $3.96M(+415.1%) |
| Dec 2015 | $768.50K(+1.7%) | $768.50K(-64.1%) |
| Sep 2015 | - | $2.14M(-77.5%) |
| Jun 2015 | - | $9.50M(+2804.3%) |
| Mar 2015 | - | $327.00K(-56.7%) |
| Dec 2014 | $755.90K(+320.9%) | $755.90K(-15.2%) |
| Jun 2014 | - | $891.50K(+1031.3%) |
| Mar 2014 | - | $78.80K |
| Dec 2013 | $179.60K(>+9900.0%) | - |
| Dec 2012 | $0.00 | - |
FAQ
- What is Viking Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Viking Therapeutics?
- What is Viking Therapeutics annual cash & cash equivalents year-on-year change?
- What is Viking Therapeutics quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Viking Therapeutics?
- What is Viking Therapeutics quarterly cash & cash equivalents year-on-year change?
What is Viking Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of VKTX is $26.68M
What is the all time high annual cash & cash equivalents for Viking Therapeutics?
Viking Therapeutics all-time high annual cash & cash equivalents is $55.52M
What is Viking Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, VKTX annual cash & cash equivalents has changed by -$28.84M (-51.95%)
What is Viking Therapeutics quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of VKTX is $37.94M
What is the all time high quarterly cash & cash equivalents for Viking Therapeutics?
Viking Therapeutics all-time high quarterly cash & cash equivalents is $195.58M
What is Viking Therapeutics quarterly cash & cash equivalents year-on-year change?
Over the past year, VKTX quarterly cash & cash equivalents has changed by -$157.64M (-80.60%)